Food Industry
35 articles on Food Industry, researched and written by the Shotlee Editorial Team from primary sources.
How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers
Philadelphia's iconic food brands are evolving, introducing high-protein and functional food options to cater to the growing number of calorie-conscious consumers, influenced by trends like GLP-1 medications and a desire for healthier choices.
8 min read
Ozempic, Wegovy, Mounjaro: Who Benefits When Obesity is Labeled a Disease?
As GLP-1 medications like Ozempic, Wegovy, and Mounjaro gain prominence, the medical community and pharmaceutical giants are increasingly framing obesity as a chronic disease. This article delves into the multifaceted implications of this classification, examining its impact on treatment, policy, and patient perception, while questioning who truly benefits from this shift.
7 min read
Ozempic, Wegovy & Mounjaro: How GLP-1s Are Reshaping the Diet Industry
The landscape of weight loss and diet trends is undergoing a seismic shift, largely driven by the widespread adoption of GLP-1 receptor agonists. From Ozempic to Wegovy and Mounjaro, these medications are not just changing how individuals manage their weight but are fundamentally altering the food industry and the very concept of dieting.
7 min read
Ozempic, Wegovy & Beyond: How GLP-1 Drugs Are Changing What We Eat
The rise of GLP-1 medications is profoundly altering consumer spending habits and food preferences, forcing the grocery industry to adapt. Discover the science behind these changes and how businesses are responding.
7 min read
The New Era of Nutrition: How GLP-1 Drugs Are Reshaping the Food Industry
The rapid adoption of GLP-1 agonists like Ozempic and Wegovy is forcing a profound realignment in the food and beverage industry. Initial hopes that users would eventually return to old habits have faded, replaced by a strategic pivot toward 'companion nutrition' tailored to the specific, evolving needs of individuals managing weight and metabolic health.
6 min read
Beyond Sugar: How One Doctor Lost 94 lbs & Silenced Food Noise
Dr. Stacy Smalley shares her transformative journey of losing 94 pounds by eliminating sugar, detailing how it silenced persistent cravings and improved her overall well-being. This article explores the science behind sugar's impact on appetite and provides actionable strategies for readers to achieve similar results.
8 min read
GLP-1 Drugs Fuel Surge in Whey Protein Demand: Industry Response
The massive adoption of GLP-1 receptor agonists for weight management is creating a significant ripple effect across the food industry, specifically driving an intense surge in demand for high-quality, muscle-preserving protein sources like whey. Dairy producers are scrambling to meet this new market reality.
6 min read
GLP-1 Weight Loss Drugs: Impact on Food Industry & Your Diet
New market data suggests a unique opportunity for protein-focused brands as GLP-1 therapies alter consumer eating habits. Learn how this shift affects your health strategy.
7 min read
GLP-1 Drugs: Reshaping Canada's Food Landscape and Consumer Habits
What began as a treatment for diabetes has rapidly evolved into a powerful force reshaping consumer behavior and Canada's agri-food economy. GLP-1 drugs are no longer niche medical interventions; they are becoming mainstream, driving significant changes in how Canadians eat and shop.
6 min read
GLP-1 Drugs and 'Ozempic Breath': A Sweet Twist for Hershey
The rise of GLP-1 medications like Ozempic and Wegovy is transforming health and lifestyles, but it's also leading to an unexpected side effect: 'Ozempic breath'. This phenomenon is creating a surprising boon for confectionary companies, particularly Hershey, as consumers seek relief. Learn more about this fascinating intersection of pharmaceuticals and consumer goods.
7 min read
GLP-1 Medications and Hot Sauce: An Unexpected Link
The rise of GLP-1 medications has led to an unexpected surge in hot sauce sales. Explore the science behind altered taste perception and how it's influencing consumer choices.
6 min read
GLP-1 Drugs Reshape Dining: How Ozempic & Co. Are Changing Menus
The rise of GLP-1 medications is no longer a whisper; it's a culinary revolution. From shrinking appetites to evolving tastes, these powerful drugs are prompting a significant shift in how we eat out, forcing restaurants to adapt their offerings and dining strategies.
7 min read
Americans Embrace Meat Industry's Protein Health Claims
More Americans are prioritizing meat for protein, with 75% seeing it as healthy—up from 64% in 2020. But experts like Tufts' Erin Hennessy caution against overfixating on meat amid industry pushes and RFK Jr.'s endorsements. Discover the health risks and smarter protein alternatives.
6 min read
Can Biopeptides Reclaim Weight Loss from GLP-1 Drugs?
As GLP-1 drugs like Ozempic transform weight loss, biotech startup Lembas argues biopeptides can reclaim a role through food-based satiety support. CEO Shay Hillel, speaking at Future Food-Tech San Francisco, positions these short proteins as complements—not replacements—for better metabolic health. With clinical trials underway, functional foods may soon enhance GLP-1 therapy.
5 min read
Mars CEO Poul Weihrauch Named Novo Nordisk Board Observer
Novo Nordisk, key supplier of GLP-1 drugs like Ozempic and Wegovy, has appointed Mars CEO Poul Weihrauch as a board observer. This move highlights the growing impact of weight-loss medications on food consumption habits. As GLP-1 use rises, food giants are adapting to shifting snack demands.
5 min read
Dairy in Good Space as GLP-1 Shifts Protein Focus, Valio Says
GLP-1 medications are suppressing appetite, prompting users to prioritize protein quality over quantity—and dairy is ideally positioned to meet this demand, says Valio's innovation chief Dr. Kevin Deegan. At the Arena Dairy Innovation Strategies conference, experts discussed how these drugs change consumer perceptions of protein and sweetness. While some users revert to old habits post-treatment, dairy's natural, high-quality proteins offer a strategic advantage.
6 min read
Farmer Blames Ozempic, Mounjaro for 'Potato Mountain' Surplus
A veteran potato farmer in Lincolnshire is staring down a 'potato mountain' of 600 tons he can't sell, blaming weight-loss drugs like Ozempic and Mounjaro. With key buyer McCain not ordering, Andy Goodacre links the surplus to slimmer appetites from GLP-1 meds. Fish friers confirm the trend is hitting chip shops too.
5 min read
GLP-1 Drugs Fuel Sauce, Spice M&A Boom as Taste Buds Dull
The surge in GLP-1 drug use among 12% of Americans is upending the food industry, with sauce and spice makers like Bachan's and Tapatio attracting high-value deals. As these medications dull taste buds and spur lean protein consumption, condiment companies are seeing explosive growth. Fast-food giants face billions in losses while flavor enhancers thrive.
5 min read
Lindt: GLP-1 Users Eating More Chocolate, Not Less
Contrary to predictions, chocolate sales are surging among GLP-1 weight-loss drug users in the U.S., according to Swiss chocolatier Lindt & Spruengli. An internal analysis reveals these households account for 17.5% of chocolate purchases, with premium varieties rising nearly 17%. This challenges assumptions about appetite suppression from drugs like Ozempic and Mounjaro.
5 min read
Snack Sales Hold Steady Despite GLP-1 Weight Loss Surge, USDA Data Shows
Despite fears that surging GLP-1 weight loss drugs would slash snack sales, new USDA data shows units holding steady at over 10 billion annually through 2024. Prescriptions rose from 0.5% to 2% of adults, yet food consumption patterns surprise economists. Discover the resilience, consumer shifts, and future outlook.
6 min read
Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands
GLP-1 medications are reshaping bakery demands, driving growth in high-fiber, high-protein products. Ardent Mills is leading with benefit-stacking strategies using UltraGrain flour and chickpea ingredients to support satiety and digestive health for users. This guide details the research, innovations, and future outlook.
6 min read
Big Food Invests Millions in Rebrands as GLP-1 Drugs Reshape Demand
Global food giants like PepsiCo and Coca-Cola are ramping up investments in rebranded, protein-rich products as GLP-1 drugs suppress appetite and alter eating habits across 20% of U.S. households. With potential $12 billion in lost snack sales over the next decade, companies are shifting to smaller portions and nutrient-dense options. This adaptation highlights the lasting ripple effects of obesity medications on the food industry.
5 min read
McDonald's Execs Plan for More GLP-1 Customers Like Ozempic Users
McDonald's executives revealed plans to cater to the growing number of customers on GLP-1 drugs like Ozempic during their latest earnings call. With users seeking high-protein options and avoiding sugary drinks, the chain is testing menu tweaks. This shift reflects broader changes in the food industry as GLP-1 adoption hits 10% of the US population.
6 min read
Meat Snacks Boom in GLP-1 Shift Like Ozempic, Popcorn Declines
Meat snacks have become the standout winner in America's GLP-1 consumption shift, surging to a $5.5 billion market as Ozempic and Wegovy users crave protein. Popcorn sales are plummeting amid this protein obsession. Discover the data, expert analysis, and how it's changing snacking habits.
5 min read
GLP-1 Drugs Reshaping Eating Habits in Connecticut
GLP-1 weight-loss drugs like Ozempic and Wegovy are changing how people in Connecticut eat, boosting demand for protein-rich foods to combat muscle loss. Nutrition experts and restaurateurs note shifts toward balanced meals and smaller portions. A clinical epidemiologist reveals how these drugs suppress appetite and delay gastric emptying for significant weight reduction.
4 min read
GLP-1 Drugs Reshape Food Economy
GLP-1 medications are revolutionizing not just weight loss but how people approach food, prioritizing protein quality over quantity. Research shows users eat less overall, including less meat, yet value nutrient-dense proteins more highly. These changes signal premiumization in the food sector and broader economic impacts. (~198 chars)
6 min read
Shake Shack Addresses Ozempic Trends With Innovative Good Fit Menu
Shake Shack is adapting to the rise of GLP-1 medications by launching a new menu focused on protein-rich choices. The Good Fit Menu provides familiar favorites with modifications for easier, more intentional eating. This shift echoes nutritional advice and reflects broader changes in fast food.
2 min read
Let Them Eat Cake: A Solution for Obesity Exists, Yet Only the Affluent Can Access It
Scientific advancements in obesity treatment have revolutionized weight management, but financial barriers ensure these benefits primarily serve the rich. From costly medications to inaccessible surgeries, the struggle reveals deep societal inequalities. Addressing this requires structural changes to make health equitable for all.
5 min read
GLP-1 Pill Clearance Drives Food Companies to Protein and Scaled-Down Servings
The recent approval of GLP-1 weight-loss pills by the FDA is influencing food companies to adapt by emphasizing protein and reducing portion sizes. Analysts predict broader adoption of these pills will accelerate changes in consumer eating habits and industry offerings. Companies like Conagra and Nestle are already reformulating products to cater to this growing market.
4 min read
The Future of Ozempic: How the Food Sector is Adapting to Weight-Loss Drug Impacts on Consumption
The food industry is facing a significant challenge due to the rise of weight-loss drugs like Ozempic, which are altering consumer preferences. Companies are now innovating to cater to a new landscape of health-conscious consumers.
6 min read
Weight-Loss Pill Approval to Spur Food Industry Product Changes
The approval of new GLP-1 weight-loss pills is anticipated to reshape the food industry, potentially leading to widespread product overhauls. Analysts foresee that the availability of these medications, particularly in pill form, will prompt significant shifts in consumer demand and industry responses.
4 min read
Agrifoodtech Trends: Insights into 2026 from GLP-1s to Continuous Fermentation
As we approach 2026, agrifoodtech founders are closely monitoring significant trends. From the influence of GLP-1 drugs on consumer choices to the transformative potential of AI and continuous fermentation, these innovations are set to reshape the industry.
9 min read
Ozempic's Impact on American Food Purchasing Habits
New research reveals that medications like Ozempic are associated with considerable decreases in household food expenditures, both in grocery stores and restaurants. The study highlights how the adoption of GLP-1 drugs impacts daily food purchasing in real-world scenarios, showing a notable shift in consumer behavior.
4 min read
GLP-1's Impact: Forecasting the Food and Beverage Sector in 2026
The increasing use of GLP-1 drugs is reshaping the food and beverage industry. Circana's research highlights how retailers and manufacturers can adapt to meet the evolving needs of health-conscious consumers.
6 min read
Ozempic's Impact: Reshaping Supermarkets and Stock Valuations
The rise in popularity of weight loss medications such as Ozempic and Mounjaro is significantly impacting both the food industry and the stock market. Eli Lilly, a pharmaceutical company, experienced a surge in valuation after reporting substantial sales increases. These drugs are changing eating patterns and redefining obesity treatment.
6 min read